AHG
Akso Health Group
There isn't enough reported data to score AHG yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
AHG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
AHG's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like AHG.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
AHG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 28x | $0.28 | -79% |
| Fair | 42x | $0.42 | -69% |
| Expensive | 45x | $0.45 | -66% |
| Current | 45x | $1.34 | — |
Historical ranges are pointers, not guarantees.
AHG's PE is 45x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
AHG Forward outlook
There aren't enough analyst estimates for AHG to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AHG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | $0.01 | +$0.17 |
| Q3 2025 | -$0.16 | -$0.14 |
| Q1 2025 | -$0.16 | -$0.09 |
| Q1 2024 | -$0.07 | -$0.05 |
| Q1 2023 | -$0.02 | +$0.26 |
| Q1 2022 | -$0.28 | +$0.43 |
| Q1 2021 | -$0.71 | +$3.67 |
| Q1 2020 | -$4.38 | -1560% |
AHG has the edge over IREN in the latest year-over-year earnings comparison.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
AHG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $6.8M | -13% |
| Q3 2025 | $7M | +0.9% |
| Q1 2025 | $7.8M | +416% |
| Q3 2024 | $6.9M | +676% |
| Q1 2024 | $1.5M | -88% |
| Q3 2023 | $893.6K | -92% |
| Q1 2023 | $13.2M | +109% |
| Q1 2022 | $6.3M | +260% |
AHG has the stronger quarterly revenue trend. Revenue is up 349% for AHG versus down 5.1% for IREN.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -282% | +134 points |
| Q3 2025 | -21% | +239 points |
| Q1 2025 | -2113% | -2005 points |
| Q3 2024 | -7.8% | +1 points |
| Q1 2024 | -416% | -163 points |
| Q3 2023 | -259% | +1502 points |
| Q1 2023 | -108% | +491 points |
| Q3 2022 | -8.8% | -17 points |
AHG's operating margin was −282% last quarter, up 134 points from the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
AHG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$14M | -334% |
| Q3 2025 | $1.2M | +$6.2M |
| Q1 2020 | -$56.2M | -$53.5M |
| Q1 2019 | -$2.7M | -103% |
| Q1 2018 | $87.3M | +$87.3M |
| Q1 2017 | $0 | -100% |
| Q4 2016 | $0 | -100% |
| Q3 2016 | $2.2M | +9.4% |
AHG's free cash flow was −$12M over the past year, against $20M the year before. Free cash flow isn't a meaningful measure for financial services companies like AHG.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
AHG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +23% | +401M shares |
| 1 year | +3061% | +2.1B shares |
| 3 years | +40619% | +2.2B shares |
AHG has 2.2B diluted shares, up 3061% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | $2.7M |
| Q1 2019 | $1.3M |
| Q1 2017 | — |
| Q4 2016 | — |
| Q3 2016 | — |
| Q2 2016 | — |
| Q1 2016 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over AHG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
AHG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2019 | -6.8x | Net Cash |
| Q1 2017 | -1.9x | Net Cash |
AHG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AHG.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
AHG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 74.8 | Neutral |
AHG's weekly RSI is 52 (neutral) and its Stochastic is 75 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
AHG PE vs Financial Services Sector
| Metric | AHG | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 13x | 244% above |
AHG is trading at 45x earnings, a 244% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
AHG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.22 | 9.8% above |
| 20 week MA | $1.21 | 11% above |
| 50 week MA | $1.49 | 10% below |
| 100 week MA | $1.48 | 9.5% below |
| 200 week MA | $1.16 | 16% above |
AHG has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
AHG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.75 | $2.31 | +32% |
| 2021 | $2.31 | $2.21 | -4.3% |
| 2022 | $2.21 | $0.40 | -82% |
| 2023 | $0.40 | $0.74 | +85% |
| 2024 | $0.74 | $1.12 | +51% |
| 2025 | $1.12 | $1.40 | +25% |
| 2026 YTD | $1.40 | $1.34 | -4.3% |
AHG has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.